Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-18-034494)

Filing Details

Accession Number:: 0001209191-18-034494
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-05-31 19:03:26
Reporting Period:: 2018-05-31

Accepted Time:: 2018-05-31 19:03:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1607678	Viking Therapeutics Inc.	VKTX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1517780	Michael Morneau	C/O Viking Therapeutics, Inc. 12340 El Camino Real, Suite 250 San Diego CA 92130	Vp, Finance And Administration	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.00001 Per Share	Disposition	2018-05-31	21,551	$9.25	94,035	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

All 21,551 of the shares were acquired on May 18, 2018 pursuant to the Issuer's 2014 Employee Stock Purchase Plan.